Biosimilars: therapeutic benefits and opportunities for savings

Maxer continues its collaboration with the IQVIA Italia Study Centre by editing the text of Farmaci biologici e biosimilari: scenari terapeutici e stima del risparmio per il Sistema Sanitario italiano. The essay analyses the evolution of the therapeutic scenarios following up the patent expiring of many originator drugs and its… read more →